Covance Genomics Laboratory and ISB to Study Gene Expression Regulation in Brain Cancer
March 29, 2011
Covance Genomics Laboratory and ISB to Study Gene Expression Regulation in Brain Cancer
According to Anup Madan, group leader for sequencing technologies at CGL, the partners will initially use RNA-seq to study the transcriptome in about 20 glioblastoma samples from partners of ISB.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: Covance's Tom Turi on the Rise of Sequencing in Drug Discovery and Development
March 29, 2011 / Clinical Sequencing News - Principal Investigator Offers Update on Luxembourg Partnership
August 27, 2010 / GenomeWeb Daily News - Defense Department Gives ISB $7.7M to ID Sepsis Biomarkers Using Next-gen Sequencing
May 31, 2013 / GenomeWeb Daily News - Covance, M2Gen Aim to Improve Patient Recruitment for Oncology Trials
February 26, 2013 / GenomeWeb Daily News - German Team Taps RNA-seq to Find Candidate Biomarkers for Detecting Steroid Abuse in Livestock
August 28, 2012 / In Sequence